Francesco Tassone

Dr. Francesco Tassone


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2009 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
FTFrancesco Tassone
Francesco Tassone
LGL. Gianotti
L. Gianotti
IEI. Emmolo
I. Emmolo
MGM. Ghio
M. Ghio
GBG. Borretta
G. Borretta
Context: The recent Third International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism (PHPT) set 60 ml/min as the precise level of glomerular filtration rate (GFR) below which surgery is recommended because it is considered a threshold of concern in patients with PHPT. Objective: The aim of the study was to investigate the relationship between different stages of renal insufficiency and PTH levels in PHPT patients. Design: We conducted a cross-sectional study. Patients and Methods: We studied 294 consecutive PHPT patients. Biochemical evaluation included total and ionized serum calcium, phosphate, creatinine, immunoreactive intact PTH, and 25-hydroxyvitamin D3 levels in the fasting state. GFR was assessed with the Modification of Diet in Renal Disease Study formula. Results: The mean GFR of the whole group of PHPT patients was 92.3 ± 31.6 ml/min · 1.73 m2. The patients were divided into four groups according to National Kidney Foundation Disease Outcomes Quality Initiative (K/DOQI) guidelines: group 1 with normal or increased GRF (>90 ml/min · 1.73 m2; n = 153); group 2 with mild decreased GFR (60–89 ml/min · 1.73 m2; n = 90); group 3 with moderately decreased GFR (30–59 ml/min · 1.73 m2; n = 45); and group 4 with severely decreased GFR (<30 ml/min · 1.73 m2; n = 6). PTH levels were comparable across groups 1–3, whereas group 4 showed significantly higher PTH levels (P < 0.0001). Conclusion: In our series of PHPT patients, only a severe impairment of GFR was characterized by a further PTH increase. These findings challenge the concept of a PTH elevation below the threshold of 60 ml/min of GFR. In a large series of contemporary PHPT patients, only a severe impairment of glomerular filtration rate (i.e., <30 ml/min/1.73 m2) is characterized by a further PTH elevation.

6 September 2021 in Endocrines
Verified
Journal Article
Open access
PDF file
Laura GianottiLaura Gianotti
Laura Gianotti
SBSara Belcastro
Sara Belcastro
SDSalvatore D'Agnano
Salvatore D'Agnano
FTFrancesco Tassone
Francesco Tassone
The hypothalamic–pituitary–adrenal axis is a tightly regulated system that represents one of the body’s mechanisms for responding to acute and chronic stress. Prolonged stress and/or inadequate regulation of the stress system can lead to a condition of chronic hypercortisolism or, in some cases, a blunted cortisol response to stress, contributing to insulin resistance, increased adiposity and type 2 diabetes mellitus. Moreover, acute and chronic stress can exacerbate or worsen metabolic conditions by supporting an inflammatory state and a tight relationship between stress, inflammation and adipose tissue has been reported and has been a growing subject of interest in recent years. We reviewed and summarized the evidence supporting hypothalamic–pituitary–adrenal axis dysregulation as an important biological link between stress, obesity, inflammation and type 2 diabetes mellitus. Furthermore, we emphasized the possible role of infectious-related stress such as SarsCov2 infection in adrenal axis dysregulation, insulin resistance and diabetes in a bidirectional link. Understanding and better defining the links between stress and obesity or diabetes could contribute to further definition of the pathogenesis and the management of stress-related complications, in which the HPA axis dysregulation has a primary role.

25 September 2009 in Diabetic Medicine
Verified
Journal Article
Closed access
PDF file
FTFrancesco Tassone
Francesco Tassone
MPM. Procopio
M. Procopio
LGL. Gianotti
L. Gianotti
GVG. Visconti
G. Visconti
APA. Pia
A. Pia
GBG. Borretta
G. Borretta

17 April 2013 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
FTFrancesco Tassone
Francesco Tassone
LGLaura Gianotti
Laura Gianotti
CBClaudia Baffoni
Claudia Baffoni
GVGianluca Visconti
Gianluca Visconti
MPMicaela Pellegrino
Micaela Pellegrino
GBGiorgio Borretta
Giorgio Borretta

24 March 2009 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
BVB. Violante
B. Violante
LGL. Gerbaudo
L. Gerbaudo
GBG. Borretta
G. Borretta
FTFrancesco Tassone
Francesco Tassone

25 October 2018 in Acta Diabetologica
Verified
Journal Article
Closed access
PDF file
FTFrancesco Tassone
Francesco Tassone
ICIda Colantonio
Ida Colantonio
EGElena Gamarra
Elena Gamarra
LGLaura Gianotti
Laura Gianotti
CBClaudia Baffoni
Claudia Baffoni
GBGiorgio Borretta
Giorgio Borretta